Determining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum.
Monoclonal antibodies (mAbs) are a growing segment of therapeutics, yet their in vitro characterization remains challenging. While it is essential that a therapeutic mAb recognizes the native, physiologically occurring epitope, the generation and selection of mAbs often rely on the use of purified r...
Main Authors: | Christine Bee, Yasmina N Abdiche, Jaume Pons, Arvind Rajpal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3819287?pdf=render |
Similar Items
-
Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer.
by: Jinte Middeldorp, et al.
Published: (2009-11-01) -
High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity.
by: Yasmina Noubia Abdiche, et al.
Published: (2014-01-01) -
Learned features of antibody-antigen binding affinity
by: Miller, Nathaniel L., et al.
Published: (2023) -
Learned features of antibody-antigen binding affinity
by: Nathaniel L. Miller, et al.
Published: (2023-02-01) -
On the Rapid Calculation of Binding Affinities for Antigen and Antibody Design and Affinity Maturation Simulations
by: Simone Conti, et al.
Published: (2022-08-01)